Tag: CBT > Cannabis Rescheduling: Page 4

Cannabis Tax Law

7 House Democrats Demand IRS, Treasury Provide 280E Cannabis Guidance

The U.S. representatives sent a letter urging ‘clear, timely guidance’ for state-licensed medical businesses following the DOJ’s rescheduling order.

May 29, 2026

Cannabis Rescheduling

ATACH Assembles Legal Team to Defend Schedule III, Defeat Prohibitionist Opponents

The American Trade Association for Cannabis and Hemp filed a formal notice to participate in the DEA hearing and retained Shane Pennington of Blank Rome.

May 28, 2026

Cannabis Rescheduling

Jushi Applies for DEA Registration of State-Licensed Medical Cannabis Operations

The multistate operator announced it is seeking expedited registration approval from the DEA under the federal Schedule III framework.

May 28, 2026

SAFE Banking Act

SAFE Banking Act Nowhere to Be Found in Wake of Schedule III Cannabis Order

The new federal posture toward loosening restrictions on cannabis does not appear to have increased congressional appetite for industry banking reform.

May 26, 2026

Finance

Curaleaf Announces 1-for-3 Reverse Stock Split in Preparation for US Stock Exchange Uplisting

In consultation with U.S. stock exchanges, the reverse stock split prepares Curaleaf for uplisting in response to U.S. cannabis rescheduling.

May 26, 2026

Cannabis Rescheduling

Cannabis Business Leans on Schedule III Listing, Asks US Tax Court to Recognize 280E Refunds for Prior Years

The IRS can’t dispute that medical cannabis falls outside the meaning of Schedule I or II ‘without contradicting the president, the acting attorney general and HHS,’ the company says.

May 21, 2026

Cannabis Rescheduling

Former Federal Prosecutor, Former IRS Lawyer Warn Cannabis Industry About Jumping on DEA Registration Bandwagon

The takeaway? Consult with experienced lawyers and tax professionals and consider the risks, as the landscape continues to shift.

May 18, 2026

Cannabis Rescheduling

Verano Submits DEA Registration Applications for Schedule III

The multistate operator filed its applications, extended to state-licensed medical cannabis businesses, following the landmark federal rescheduling order.

May 13, 2026

Cannabis Rescheduling

DEA’s Schedule III Cannabis Registration ‘Coming Soon’ For Cultivators, Manufacturers, Distributors, Labs

The application for non-dispensary businesses to handle Schedule III medical cannabis will be available in the coming weeks.

May 11, 2026

Pesticides

Schedule III's Potential Impact on Cannabis Pesticide Regulations

In a regulatory environment where federal guidance is absent and state rules vary, will rescheduling provide an industry standard on pesticide use?

May 11, 2026

Cannabis Rescheduling

Glass House Brands Applies for DEA Registration of Certain Medical Operations

The California cannabis company submitted its application for the expedited registration pathway established in the federal Schedule III order.

May 6, 2026

Cannabis Rescheduling

New Medical Cannabis Expansion Era Could Ignite Under Schedule III

California is streamlining its licensing process; New Jersey could consider allowing adult-use licensees to become dual-use; and D.C. already has a loophole.

May 4, 2026